MSD Licenses Molnupiravir In India

Nuances, Local Data In Focus

Merck
Merck Outlines Plans To Accelerate Access To Its Investigational Antiviral
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Deals

More from Business